Experts estimate we’ll see 1,898,160 new cancer diagnoses in the United States in 2021 alone. While go-to treatments such as chemo and radiation are still widely used to help combat the disease, there is a new class of therapies focused on harnessing the healing power of our own immune system. Brian McKelligon, CEO of Akoya Biosciences, joins kathy ireland to discuss the cutting-edge field of spatial biology and how analyzing cellular activity at a single-cell level can unlock major clinical breakthroughs.

“Akoya is excited to bring unprecedented power, scale, and automation to histology and single-cell analysis through our multiplex immunofluorescence solutions. With both the Phenoptics and CODEX portfolios, we provide our customers with a full suite of end-to-end solutions for high parameter tissue analysis.” – Brian McKelligon

Visit Akoya Biosciences to find out more.